Medical Weight Loss for Newport News, Virginia Residents

Newport News, Virginia residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Newport News through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

No clinic to drive to in Newport News: Dr. Anjmun Sharma reviews your health by video, and your compounded semaglutide or tirzepatide ships straight to your Virginia address. Nothing to pick up, no waiting room, no local office needed. Doctor review just $119 (medication separate).

Why Newport News Residents Choose New Hope Weight Loss

We made New Hope easy to start without making it less serious. A Newport News patient can go from first visit to a physician-approved plan without insurance paperwork, prior authorizations, or a single drive to an office. The $119 review with Dr. Anjmun Sharma is flat, the medication price is published, and the whole thing happens by telehealth. Low friction to begin, real medicine once you do, the same standard everyone in Virginia gets.

Medical weight loss for Newport News is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

New Hope Weight Loss is based in Costa Mesa, yet a patient in Newport News sees the same doctor, takes the same approach, and pays the same prices, all through telehealth across Virginia. We care for patients throughout Downtown, City Center, and the greater Hampton Roads area. A licensed care coordinator stays reachable by message and phone, so help is a few taps away anywhere in Virginia.

You can start this week from anywhere in Virginia, because telehealth removes the drive, the parking, and the weeks of waiting that a local clinic would require. Between Klarna, Affirm, and HSA or FSA cards, Newport News patients have several ways to handle the $119 review and ongoing medication payments. New Hope Weight Loss serves patients throughout Virginia entirely by telehealth from our Costa Mesa, California clinic, delivering physician-supervised GLP-1 programs without an office visit.

GLP-1 Weight Loss Programs Available

Compounded GLP-1 care, supervised by a physician

The 90-Day Metabolic Reset is built on semaglutide, the same active ingredient you will find in Wegovy and Ozempic. It is priced from $166/mo, with the complete 90-day program at $499, and branded-drug trials averaged about 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved, not brand-identical, and results vary by person. Dr. Sharma manages your care by telehealth, wherever you are in Newport News.

Prefer the dual-action route? Tirzepatide

From $233/mo, tirzepatide works on GLP-1 and GIP together. In branded-drug trials, dose-qualified patients reached up to 22.5 percent loss, a peak number that is not typical. Same active ingredient as Mounjaro and Zepbound.

It all starts with a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Newport News

Telehealth means your weight-loss care travels to you instead of the other way around. Patients across Newport News and the rest of start with a detailed online quiz covering medical history and goals. Dr. Anjmun Sharma personally reviews each intake and connects by secure video, usually inside 48 hours, to decide together whether a compounded GLP-1 is right. When she writes a prescription, the medication is filled by a state-licensed 503(a) pharmacy and mailed to your Newport News door in temperature-controlled cold-pack packaging. Ongoing follow-ups also happen by video, keeping your plan on track without a single in-person appointment.

Frequently Asked Questions, Newport News

Is New Hope Weight Loss available to Newport News without a local branch?

Yes, even though we have no branch in Newport News. Our one physical clinic is in Costa Mesa, California, and we reach Newport News, Virginia through telehealth. A secure video consult with Dr. Anjmun Sharma is where your medical history is reviewed and your fit for a compounded GLP-1 plan is confirmed.

From Newport News, can I avoid traveling for appointments?

You can skip travel entirely. The program is built around telehealth, so Newport News patients meet the doctor online, complete intake digitally, and stay connected by message. If approved, medication ships to your Newport News home in cold-pack packaging that maintains a safe temperature on the way.

What will Newport News patients spend on the program?

Expect $119 for the physician visit. Compounded semaglutide is offered from $166 per month or $499 for 90 days, and tirzepatide from $233 per month. The medication is billed separately. HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge for Newport News residents at all.

What areas of Newport News do you serve?

We serve patients from across Newport News by telehealth, including Downtown, City Center, and the greater Hampton Roads area.

How is medication shipped to Newport News patients?

After Dr. Sharma approves your plan, compounded medication ships in discreet, temperature-appropriate packaging directly to your Newport News address from the identified 503(a) compounding pharmacy. Most patients receive it within days, with no pharmacy line and no drive.

Newport News Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Newport News, Virginia by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.